# CELF2 Promotes Tau Exon 10 Inclusion via Hinge Domain-Mediated Nuclear Condensation, Driving Cognitive Dysfunction in Tauopathy Models

**Authors:** Lizhen Chen

PMC · DOI: 10.21203/rs.3.rs-8555050/v1 · Research Square · 2026-01-19

## TL;DR

This study shows how the protein CELF2 controls tau splicing through nuclear condensation, impacting cognitive function in neurodegenerative diseases.

## Contribution

The study reveals a novel condensate-based mechanism by which CELF2 regulates tau exon 10 splicing through its hinge domain.

## Key findings

- CELF2 promotes tau exon 10 inclusion via its hinge domain's intrinsically disordered region.
- CELF2 condensates colocalize with tau RNA and interact with splicing regulators NOVA2 and SFPQ.
- A conserved residue in CELF2's IDR is essential for condensate formation and splicing activity.

## Abstract

Alternative splicing is a fundamental mechanism underlying protein diversity. The microtubule-associated protein tau (MAPT) undergoes age-associated alternative splicing of exon 10 to generate 3R and 4R isoforms, and disruption of the 4R:3R ratio is a central feature of tauopathies. However, the molecular mechanisms regulating tau exon 10 splicing remain incompletely understood. Here, we identify the RNA-binding protein CELF2 as a key promoter of tau exon 10 inclusion. Loss of CELF2 in the mouse brain reduces exon 10 inclusion, resulting in a decreased 4R:3R ratio. We show that an intrinsically disordered region (IDR) within the CELF2 hinge domain drives protein condensation and is essential for its splicing activity. This IDR can be functionally substituted by those of FUS or TAF15. CRISPR-based imaging reveals colocalization of CELF2 condensates with tau RNA. Proteomic analyses identify NOVA2 and SFPQ as CELF2 interactors, which co-condense with CELF2 to cooperatively regulate tau exon 10 splicing. A conserved negatively charged residue (D388) within the IDR is critical for condensate formation, protein interactions, and splicing function. Finally, CELF2 condensation capacity correlates with 4R tau expression in vivo and influences locomotor and cognitive performance. These findings uncover a condensate-based mechanism for tau splicing regulation with implications for tau-related neurodegeneration.

## Linked entities

- **Genes:** MAPT (microtubule associated protein tau) [NCBI Gene 4137], CELF2 (CUGBP Elav-like family member 2) [NCBI Gene 10659], NOVA2 (NOVA alternative splicing regulator 2) [NCBI Gene 4858], SFPQ (splicing factor proline and glutamine rich) [NCBI Gene 6421], FUS (FUS RNA binding protein) [NCBI Gene 2521], TAF15 (TATA-box binding protein associated factor 15) [NCBI Gene 8148]
- **Proteins:** MAPT (microtubule associated protein tau), CELF2 (CUGBP Elav-like family member 2), NOVA2 (NOVA alternative splicing regulator 2), SFPQ (splicing factor proline and glutamine rich), FUS (FUS RNA binding protein), TAF15 (TATA-box binding protein associated factor 15)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Sfpq (splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated)) [NCBI Gene 71514] {aka 1110004P21Rik, 2810416M14Rik, 5730453G22Rik, 9030402K04Rik, D4Ertd314e, Gm12940}, Nova2 (NOVA alternative splicing regulator 2) [NCBI Gene 384569] {aka Gm1424}, Fus (fused in sarcoma) [NCBI Gene 233908] {aka D430004D17Rik, D930039C12Rik, Fus1, Tls}, Celf2 (CUGBP, Elav-like family member 2) [NCBI Gene 14007] {aka B230218O03, B230345P09Rik, CELF-2, CUG-BP2, Cugbp2, D230046B21Rik}, Mapt (microtubule-associated protein tau) [NCBI Gene 17762] {aka Mtapt, PHF-tau, Tau}, Taf15 (TATA-box binding protein associated factor 15) [NCBI Gene 70439] {aka 2610111C21Rik, 68kDa, TAFII68, Taf2n}
- **Diseases:** Tauopathy (MESH:D024801), neurodegeneration (MESH:D019636), Cognitive Dysfunction (MESH:D003072)
- **Chemicals:** 4R (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12869637/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12869637/full.md

## References

87 references — full list in the complete paper: https://tomesphere.com/paper/PMC12869637/full.md

---
Source: https://tomesphere.com/paper/PMC12869637